Share Buyback in H. Lundbeck A/S


Acting on its authorization to acquire up to 10% of its shares,
Lundbeck's Supervisory Board has resolved to initiate a share buyback
program. Under the program Lundbeck will buy own shares for an amount
of up to DKK 6 billion, cf. stock exchange announcement number 166
dated 17 August 2005. The buyback program is expected to be completed
by the end of 2008.

During any one single trading day a maximum of 25% of the average
daily trading volume of Lundbeck shares on OMX Nordic Exchange
Copenhagen, calculated over 20 days prior to each trading date, will
be bought back, as the share buyback program is implemented in
accordance with the provisions of the European Commission's
regulation no. 2273/2003 of December 22, 2003.

At least once every seven trading days, Lundbeck will issue an
announcement in respect of the transactions made under the program.

The following transactions have been made under the program:


                       No. of shares        Average Transaction value
                                     purchase price             (DKK)
                                              (DKK)
Accumulated, last         29,841,323       133.6117     3,987,150,581
announcement
6 May 2008                    67,161       120.7203      8,107,698.08
7 May 2008                        --             --                --
8 May 2008                        --             --                --
9 May 2008                    95,700       129.6848     12,410,836.32
13 May 2008                   97,400       128.1941     12,486,101.93
14 May 2008                   94,000       125.7829     11,823,588.84
15 May 2008                       --             --                --
Accumulated under the     30,195,584       133.5288     4,031,978,806
program



Following the above buyback it is hereby announced that Lundbeck owns
a total of 11,038,797 own shares at a nominal value of DKK 5, equal
to 5.33% of the total number of 207,279,631 shares.

Lundbeck contacts


Investors:                 Media:

Jacob Tolstrup             Jens Harder Højbjerg
Director                   Media Relations Manager
+45 36 43 30 79            +45 36 43 28 33

Palle Holm Olesen
Head of Investor Relations
+45 36 43 24 26


Stock Exchange Release No 342 - 15 May 2008

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2007,
the company's revenue was DKK 11 billion (approximately EUR 1.5
billion or USD 2.0 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com

Attachments

Release No 342 in pdf format